Evidence map›Paper›PMID 19451231›Full record

ArticleMolecular and cellular biology2009

Chromatin structure is implicated in "late" elongation checkpoints on the U2 snRNA and beta-actin genes.

Sylvain Egloff, Hadeel Al-Rawaf, Dawn O'Reilly, Shona Murphy

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. CDK9 keeps RNA polymerase II on track.Cellular and molecular life sciences : CMLS · 2021
    Review
  4. Article
  5. Review
  6. Review
  7. RNA polymerase II pausing as a context-dependent reader of the genome.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2016
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sylvain EgloffSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom.
Hadeel Al-Rawaf
Dawn O'Reilly
Shona Murphy
University of Oxford · GB

Funding

Medical Research Council G0400653Medical Research Council G9826944Wellcome Trust
6 · The paper itself

Abstract

The negative elongation factor NELF is a key component of an early elongation checkpoint generally located within 100 bp of the transcription start site of protein-coding genes. Negotiation of this checkpoint and conversion to productive elongation require phosphorylation of the carboxy-terminal domain of RNA polymerase II (pol II), NELF, and DRB sensitivity-inducing factor (DSIF) by positive transcription elongation factor b (P-TEFb). P-TEFb is dispensable for transcription of the noncoding U2 snRNA genes, suggesting that a NELF-dependent checkpoint is absent. However, we find that NELF at the end of the 800-bp U2 gene transcription unit and RNA interference-mediated knockdown of NELF causes a termination defect. NELF is also associated 800 bp downstream of the transcription start site of the beta-actin gene, where a "late" P-TEFb-dependent checkpoint occurs. Interestingly, both genes have an extended nucleosome-depleted region up to the NELF-dependent control point. In both cases, transcription through this region is P-TEFb independent, implicating chromatin in the formation of the terminator/checkpoint. Furthermore, CTCF colocalizes with NELF on the U2 and beta-actin genes, raising the possibility that it helps the positioning and/or function of the NELF-dependent control point on these genes.

Indexed as

ActinsBinding SitesCCCTC-Binding FactorChromatinDNA-Binding ProteinsDNA Polymerase IIHeLa CellsHigh Mobility Group ProteinsHumansModels, BiologicalNuclear ProteinsNucleosomesPhosphorylationPositive Transcriptional Elongation Factor BPromoter Regions, GeneticProtein Structure, TertiaryActinsCCCTC-Binding FactorChromatinCTCF protein, humanDNA-Binding ProteinsDNA Polymerase IIHigh Mobility Group Proteinsnegative elongation factorNuclear ProteinsNucleosomesPositive Transcriptional Elongation Factor BRecombinant ProteinsRepressor ProteinsRNA, Small InterferingRNA, Small NuclearSSRP1 protein, humanSUPT5H protein, humanTranscriptional Elongation FactorsTranscription Factorstranscription factor S-IIU2 small nuclear RNA

Identifiers

PMID19451231
PMCPMC2704739
OpenAlexW2151260830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.